Chris: Did you hear the CC? Gerald said our agreement with ICON could turn into something more down the road....but he also talked about how competition next year between Big Pharmas wanting to use LymPro is what could produce the kind of value Gerald would like. That sounds like a year away, not 2 or 3 months away.

Revenue for LymPro will begin in Jan. 2015, but it will be modest. It will ramp up well by the second half of the year. So I don't know how much pps pop it will give us in December when we up list? These are the two major reasons I think the up listing has been pushed back into 2015.

Orphans in December will help some, but not enough to get us above .20 or .25 cents. Jason Napodano still gives us a Price Target of .20 cents by year end.